Literature DB >> 10986305

Radiographic damage of large joints in long-term rheumatoid arthritis and its relation to function.

K W Drossaers-Bakker1, H M Kroon, A H Zwinderman, F C Breedveld, J M Hazes.   

Abstract

OBJECTIVE: To describe the extent of radiographic damage of large joints in long-term rheumatoid arthritis (RA) and its relationship to small joint involvement and physical function.
METHODS: After 12 yr of follow-up, radiographs of all large joints (Larsen large joint score 0-60) of 105 recent RA patients were assessed. Correlations were evaluated between the Larsen large joint score and radiographic damage of the hands and feet as measured by the van der Heijde modification of the Sharp score (SHS) and the health assessment questionnaire (HAQ). We determined the relative contributions of radiographic damage of small and large joints, disease activity and psychological function to the HAQ.
RESULTS: The median Larsen large joint score was 3. In 54% of the patients at least one large joint was erosive. The correlation of the Larsen score with the SHS and HAQ scores was 0.76 and 0.60, respectively. Disease activity and radiographic damage of the large joints were the major determinants of the HAQ score.
CONCLUSION: Large joint involvement after 12 yr of follow-up is extensive and is associated with functional disability. Large joint involvement is closely associated with small joint involvement.

Entities:  

Mesh:

Year:  2000        PMID: 10986305     DOI: 10.1093/rheumatology/39.9.998

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  26 in total

1.  Radiographic progression in rheumatoid arthritis: does it reflect outcome? Does it reflect treatment?

Authors:  D van der Heijde
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

2.  Articular damage in late rheumatoid arthritis.

Authors:  Emel Eksioglu; Reyhan Tuncay; Eda Gurcay; Ajda Bal; Aytul Cakci
Journal:  Clin Rheumatol       Date:  2006-04-22       Impact factor: 2.980

Review 3.  Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors:  Iñigo Bermejo; Shijie Ren; Emma Simpson; Mark Clowes; David L Scott; Adam Young; Matt Stevenson
Journal:  Pharmacoeconomics       Date:  2018-12       Impact factor: 4.981

4.  Severity of rheumatoid arthritis: the SEVERA study.

Authors:  Rafic Baddoura; Souha Haddad; Hassane Awada; Abdel Fattah Al-Masri; Georges Merheb; Said Attoui; Jad Okais; Jamil Messayke; Fadi Ghandour
Journal:  Clin Rheumatol       Date:  2005-12-15       Impact factor: 2.980

Review 5.  Multimorbidity and rheumatic conditions-enhancing the concept of comorbidity.

Authors:  Helga Radner; Kazuki Yoshida; Josef S Smolen; Daniel H Solomon
Journal:  Nat Rev Rheumatol       Date:  2014-01-14       Impact factor: 20.543

6.  Muscle strength, pain, and disease activity explain individual subdimensions of the Health Assessment Questionnaire disability index, especially in women with rheumatoid arthritis.

Authors:  A Häkkinen; H Kautiainen; P Hannonen; J Ylinen; H Mäkinen; T Sokka
Journal:  Ann Rheum Dis       Date:  2005-05-18       Impact factor: 19.103

Review 7.  Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Authors:  Lesley Uttley; Iñigo Bermejo; Shijie Ren; Marrissa Martyn-St James; Ruth Wong; David L Scott; Adam Young; Matt Stevenson
Journal:  Pharmacoeconomics       Date:  2018-09       Impact factor: 4.981

Review 8.  Prevention or retardation of joint damage in rheumatoid arthritis: issues of definition, evaluation and interpretation of plain radiographs.

Authors:  Maarten Boers; Désirée M F M van der Heijde
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  Pain and joint mobility explain individual subdimensions of the health assessment questionnaire (HAQ) disability index in patients with rheumatoid arthritis.

Authors:  A Häkkinen; H Kautiainen; P Hannonen; J Ylinen; M Arkela-Kautiainen; T Sokka
Journal:  Ann Rheum Dis       Date:  2004-05-06       Impact factor: 19.103

10.  Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial.

Authors:  Susanne J J Claessen; Johanna M W Hazes; Margriet A M Huisman; Derkjen van Zeben; Jolanda J Luime; Angelique E A M Weel
Journal:  BMC Musculoskelet Disord       Date:  2009-06-18       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.